Allogene Therapeutics's chart data is dated 2026-10-09. There is no active technical signal. There are 0 published signal records.
Allogene Therapeutics last closed at $1.46 (+4.29%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -2.9×. Its overall grade ranks 224 of 736 stocks in Healthcare.
About this company
Allogene Therapeutics last closed at $1.46 (+4.29%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 224/736
Valuation grade B-
Related stocks
- AbbVieCustomer
CAR-T 협업·라이선스 대상 가능성이 큰 대형 제약사
- Bristol Myers SquibbCompetitor
세포치료제와 혈액암 면역치료 분야의 주요 경쟁사
- Gilead SciencesCompetitor
Kite를 통해 CAR-T 시장의 대표 경쟁자
About Allogene Therapeutics
- What technical signals does Allogene Therapeutics (ALLO) have?
- Allogene Therapeutics current technical signals: no active technical signal.
- Is Allogene Therapeutics a cup-and-handle pattern?
- No. Allogene Therapeutics has no valid Cup signal right now.
- What published figures are available for Allogene Therapeutics?
- Market cap: $328.11M. Trailing 12 months PER: -2.9×. Latest quarter PBR: 1.10×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-10 dataset
Turn what you saw on this name into a strategy
Ask Q about Allogene Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.